Graph Perceiver Network for Lung Tumor and Bronchial Premalignant Lesion Stratification from Histopathology
- PMID: 38588853
- PMCID: PMC11220922
- DOI: 10.1016/j.ajpath.2024.03.009
Graph Perceiver Network for Lung Tumor and Bronchial Premalignant Lesion Stratification from Histopathology
Abstract
Bronchial premalignant lesions (PMLs) precede the development of invasive lung squamous cell carcinoma (LUSC), posing a significant challenge in distinguishing those likely to advance to LUSC from those that might regress without intervention. This study followed a novel computational approach, the Graph Perceiver Network, leveraging hematoxylin and eosin-stained whole slide images to stratify endobronchial biopsies of PMLs across a spectrum from normal to tumor lung tissues. The Graph Perceiver Network outperformed existing frameworks in classification accuracy predicting LUSC, lung adenocarcinoma, and nontumor lung tissue on The Cancer Genome Atlas and Clinical Proteomic Tumor Analysis Consortium datasets containing lung resection tissues while efficiently generating pathologist-aligned, class-specific heatmaps. The network was further tested using endobronchial biopsies from two data cohorts, containing normal to carcinoma in situ histology. It demonstrated a unique capability to differentiate carcinoma in situ lung squamous PMLs based on their progression status to invasive carcinoma. The network may have utility in stratifying PMLs for chemoprevention trials or more aggressive follow-up.
Copyright © 2024 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.
Figures





References
-
- Beane J.E., Mazzilli S.A., Campbell J.D., Duclos G., Krysan K., Moy C., Perdomo C., Schaffer M., Liu G., Zhang S., Liu H., Vick J., Dhillon S.S., Platero S.J., Dubinett S.M., Stevenson C., Reid M.E., Lenburg M.E., Spira A.E. Molecular subtyping reveals immune alterations associated with progression of bronchial premalignant lesions. Nat Commun. 2019;10:1856. - PMC - PubMed
-
- Merrick D.T., Edwards M.G., Franklin W.A., Sugita M., Keith R.L., Miller Y.E., Friedman M.B., Dwyer-Nield L.D., Tennis M.A., O'Keefe M.C., Donald E.J., Malloy J.M., van Bokhoven A., Wilson S., Koch P.J., O'Shea C., Coldren C., Orlicky D.J., Lu X., Baron A.E., Hickey G., Kennedy T.C., Powell R., Heasley L., Bunn P.A., Geraci M., Nemenoff R.A. Altered cell-cycle control, inflammation, and adhesion in high-risk persistent bronchial dysplasia. Cancer Res. 2018;78:4971–4983. - PMC - PubMed
-
- Mascaux C., Angelova M., Vasaturo A., Beane J., Hijazi K., Anthoine G., Buttard B., Rothe F., Willard-Gallo K., Haller A., Ninane V., Burny A., Sculier J.-P., Spira A., Galon J. Immune evasion before tumour invasion in early lung squamous carcinogenesis. Nature. 2019;571:570–575. - PubMed
-
- Ning B., Tilston-Lunel A.M., Simonetti J., Hicks-Berthet J., Matschulat A., Pfefferkorn R., Spira A., Edwards M., Mazzilli S., Lenburg M.E., Beane J.E., Varelas X. Convergence of YAP/TAZ, TEAD and TP63 activity is associated with bronchial premalignant severity and progression. J Exp Clin Cancer Res. 2023;42:116. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical